Additional file 6: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration

Genes differentially expressed immediately following the repeated sprint tests vs. baseline prior to and after the rHuEpo/placebo injection in the MDS, respectively. (XLS 21Â kb)

本数据集包含骨髓增生异常综合征（Myelodysplastic Syndromes, MDS）队列中的差异表达基因：在该队列中，分别于重组人促红细胞生成素（recombinant human erythropoietin, rHuEpo）或安慰剂注射前的基线状态、以及注射后的基线状态下，对重复冲刺测试后即刻采集的样本进行基因表达检测，得到与对应基线水平相比存在显著差异的基因。本数据集文件为XLS格式，大小21千字节。